No link between Merck's Gardasil and MS risk, study shows

Merck's Gardasil HPV vaccine--FierceBiotech file photo
Merck's Gardasil

Merck ($MRK) and partner Sanofi ($SNY) can breathe easy: According to a new study, their blockbuster HPV shot Gardasil isn't linked to an increased risk of multiple sclerosis. In a study published Tuesday in JAMA, researchers found that in a population of 3.9 million girls and women, those vaccinated with Gardasil had lower rates of MS and similar CNS diseases. Story

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.

Univercells's new CDMO, Exothera, is hoping to play a role in helping drugmakers scale up manufacturing for a possible COVID-19 vaccine.